Cost & Insurance

Compare GLP-1 medication costs, insurance options, manufacturer savings and provider fees. Understand the difference between a medication price and the full cost of a program, then explore the providers in our approved partner comparison.

Wegovy may qualify for the $50 Medicare GLP-1 Bridge; Ozempic is not included. Compare the exact medication, reason for treatment and coverage route before paying.

Ozempic is not FDA-approved for PCOS. It is approved for type 2 diabetes. The 2023 international PCOS guideline says semaglutide may be considered, alongside active lifestyle intervention, for weight management in adults with PCOS and higher weight under general-population criteria. That is different from an approval to treat PCOS or infertility. Coverage depends on the prescribed product, approved indication, plan formulary and prior-authorization rules. This guide separates the evidence from the labels, then compares realistic coverage and cash-pay paths.

FDA resolved the semaglutide shortage on February 21, 2025 and ended temporary shortage-based enforcement discretion on April 22 for 503A pharmacies and May 22 for 503B facilities. This guide separates those dates from FDA's pending 503B bulk-list proposal and compares paths to discuss with a prescriber.

Gala's current tirzepatide-microdose offer lists $149/mo for three months. Other examples: LillyDirect brand Zepbound at $299 for 2.5mg, $399 for 5mg, and $449 for 7.5mg and higher doses when refill conditions are met. Compare medication, program fees and plan terms before ranking prices.

Tirzepatide's shortage was resolved in October 2024 and shortage-based enforcement discretion ended in early 2025. This guide compares advertised compounded prices with brand Zepbound and explains why legality, formulation, and safety cannot be inferred from availability alone.